These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33746750)

  • 1. What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences.
    Petrocchi S; Janssens R; Oliveri S; Arnou R; Durosini I; Guiddi P; Louis E; Vandevelde M; Nackaerts K; Smith MY; Galli G; de Marinis F; Gianoncelli L; Pravettoni G; Huys I
    Front Pharmacol; 2021; 12():602112. PubMed ID: 33746750
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients.
    Durosini I; Janssens R; Arnou R; Veldwijk J; Smith MY; Monzani D; Smith I; Galli G; Garassino M; Katz EG; Bailo L; Louis E; Vandevelde M; Nackaerts K; de Wit GA; Pravettoni G; Huys I
    Front Public Health; 2021; 9():622154. PubMed ID: 33634069
    [No Abstract]   [Full Text] [Related]  

  • 3. Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy.
    Janssens R; Arnou R; Schoefs E; Petrocchi S; Cincidda C; Ongaro G; Oliveri S; Smith MY; Louis E; Vandevelde M; Nackaerts K; Pravettoni G; Huys I
    Front Pharmacol; 2021; 12():710518. PubMed ID: 34630085
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting.
    Monzani D; Petrocchi S; Oliveri S; Veldwijk J; Janssens R; Bailo L; Smith MY; Smith I; Schoefs E; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Katz EG; Petrella F; Casiraghi M; Durosini I; Galli G; Garassino MC; de Wit GA; Pravettoni G; Huys I
    Front Med (Lausanne); 2021; 8():689114. PubMed ID: 34409049
    [No Abstract]   [Full Text] [Related]  

  • 5. How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action.
    Janssens R; Barbier L; Muller M; Cleemput I; Stoeckert I; Whichello C; Levitan B; Hammad TA; Girvalaki C; Ventura JJ; Bywall KS; Pinto CA; Schoefs E; Katz EG; Kihlbom U; Huys I
    Front Pharmacol; 2023; 14():1192770. PubMed ID: 37663265
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study.
    Janssens R; Lang T; Vallejo A; Galinsky J; Plate A; Morgan K; Cabezudo E; Silvennoinen R; Coriu D; Badelita S; Irimia R; Anttonen M; Manninen RL; Schoefs E; Vandebroek M; Vanhellemont A; Delforge M; Stevens H; Simoens S; Huys I
    Front Med (Lausanne); 2021; 8():686165. PubMed ID: 34295912
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Patient Preference Information in Benefit-Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and Initiatives.
    Chachoua L; Dabbous M; François C; Dussart C; Aballéa S; Toumi M
    Front Med (Lausanne); 2020; 7():543046. PubMed ID: 33195294
    [No Abstract]   [Full Text] [Related]  

  • 8. Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study.
    van Overbeeke E; Janssens R; Whichello C; Schölin Bywall K; Sharpe J; Nikolenko N; Phillips BS; Guiddi P; Pravettoni G; Vergani L; Marton G; Cleemput I; Simoens S; Kübler J; Juhaeri J; Levitan B; de Bekker-Grob EW; Veldwijk J; Huys I
    Front Pharmacol; 2019; 10():1395. PubMed ID: 31849657
    [No Abstract]   [Full Text] [Related]  

  • 9. Exploring the Important Determinants Shaping Treatment Preferences: Qualitative Insights into Breast Cancer Patient Experiences and Perspectives in New Zealand.
    Yeo HY; Wong JHY; Chan SJ; Latu ATF; Han CH; Anwar M; Marra CA
    Patient Prefer Adherence; 2023; 17():3525-3537. PubMed ID: 38148974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.
    Rocque GB; Rasool A; Williams BR; Wallace AS; Niranjan SJ; Halilova KI; Turkman YE; Ingram SA; Williams CP; Forero-Torres A; Smith T; Bhatia S; Knight SJ
    Oncologist; 2019 Oct; 24(10):1313-1321. PubMed ID: 30872466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What matters in clinical trial decision-making: a systematic review of interviews exploring cancer patients' experiences.
    Gregersen TA; Birkelund R; Wolderslund M; Netsey-Afedo ML; Steffensen KD; Ammentorp J
    Scand J Caring Sci; 2019 Jun; 33(2):266-278. PubMed ID: 30735263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer.
    Moth E; McLachlan SA; Veillard AS; Muljadi N; Hudson M; Stockler MR; Blinman P
    Lung Cancer; 2016 May; 95():8-14. PubMed ID: 27040845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review of Patients' and Parents' Preferences for ADHD Treatment Options and Processes of Care.
    Schatz NK; Fabiano GA; Cunningham CE; dosReis S; Waschbusch DA; Jerome S; Lupas K; Morris KL
    Patient; 2015 Dec; 8(6):483-97. PubMed ID: 25644223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient centered decision making: use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
    Wilson L; Loucks A; Bui C; Gipson G; Zhong L; Schwartzburg A; Crabtree E; Goodin D; Waubant E; McCulloch C
    J Neurol Sci; 2014 Sep; 344(1-2):80-7. PubMed ID: 25037284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older Adults' Views and Communication Preferences About Cancer Screening Cessation.
    Schoenborn NL; Lee K; Pollack CE; Armacost K; Dy SM; Bridges JFP; Xue QL; Wolff AC; Boyd C
    JAMA Intern Med; 2017 Aug; 177(8):1121-1128. PubMed ID: 28604917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Preference Studies for Advanced Prostate Cancer Treatment Along the Medical Product Life Cycle: Systematic Literature Review.
    Menges D; Piatti MC; Cerny T; Puhan MA
    Patient Prefer Adherence; 2022; 16():1539-1557. PubMed ID: 35789822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck cancer patients' preferences for individualized prognostic information: a focus group study.
    Hoesseini A; Dronkers EAC; Sewnaik A; Hardillo JAU; Baatenburg de Jong RJ; Offerman MPJ
    BMC Cancer; 2020 May; 20(1):399. PubMed ID: 32380962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment recommendations by clinicians in stage I non-small cell lung cancer: A study of factors that influence the likelihood of accounting for the patient's preference.
    Hopmans W; Damman OC; Porsius JT; Zwaan L; Senan S; Timmermans DR
    Patient Educ Couns; 2016 Nov; 99(11):1808-1813. PubMed ID: 27372523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.